Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as

Olli Dufva1, Matti Kankainen2,3, Tiina Kelkka1

  • 1Hematology Research Unit Helsinki, University of Helsinki and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, FIN-00290, Helsinki, Finland.

Nature Communications
|April 21, 2018
PubMed

Insights

Aggressive natural killer-cell leukemia (ANKL) genetics reveal key mutations in STAT3, RAS-MAPK, DDX3X, and epigenetic modifiers. NK cells show sensitivity to JAK and BCL2 inhibition, offering new therapeutic targets.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Aggressive natural killer-cell leukemia (ANKL) is a rare and aggressive cancer with poor outcomes.
  • Current treatment options for ANKL are limited, highlighting the need for targeted therapies.

Purpose of the Study:

  • To elucidate the molecular pathogenesis of ANKL through comprehensive genomic and drug sensitivity profiling.
  • To identify potential therapeutic targets for ANKL and related NK-cell malignancies.

Main Methods:

  • Whole-exome sequencing (WES) was performed on 14 ANKL patient samples.
  • Genomic data from public databases were integrated to identify recurrent alterations.
  • Drug sensitivity profiling was conducted to assess the response of NK cells to targeted inhibitors.

Main Results:

  • Mutations were identified in STAT3 (21%), RAS-MAPK pathway genes (21%), DDX3X (29%), and epigenetic modifiers (50%).
  • JAK-STAT copy gains and tyrosine phosphatase mutations were found to be recurrent in ANKL and extranodal NK/T-cell lymphoma, nasal type (NKTCL).
  • NK cells demonstrated high sensitivity to JAK and BCL2 inhibition compared to other hematopoietic cell lineages.

Conclusions:

  • The study provides critical insights into the genetic landscape of ANKL.
  • Identified genetic alterations and drug sensitivities offer a framework for developing targeted therapies for ANKL and other NK-cell malignancies.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
12.7K
Aggression01:47

Aggression

Humans engage in aggression when they seek to cause harm or pain to another person. Aggression takes two forms depending on one’s motives: hostile or instrumental. Hostile aggression is motivated by feelings of anger with intent to cause pain; a fight in a bar with a stranger is an example of hostile aggression. In contrast, instrumental aggression is motivated by achieving a goal and does not necessarily involve intent to cause pain (Berkowitz, 1993); a contract killer who murders for...
30.4K
Mutations01:39

Mutations

Overview
94.6K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
131.1K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
859